Mesalazine granules promote disease clearance in patients with mild‐to‐moderate ulcerative colitis

BACKGROUND: Over the past decade, treatment targets for ulcerative colitis (UC) have become more stringent, incorporating multiple parameters. Recently, the concept of ‘disease clearance’—defined as combined clinical, endoscopic, and histological remission—has been proposed as an ultimate endpoint i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruis, Wolfgang, Meszaros, Silke, Wehrum, Sarah, Mueller, Ralph, Greinwald, Roland, Nacak, Tanju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576598/
https://www.ncbi.nlm.nih.gov/pubmed/37490352
http://dx.doi.org/10.1002/ueg2.12435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576598/
https://www.ncbi.nlm.nih.gov/pubmed/37490352
http://dx.doi.org/10.1002/ueg2.12435

Ejemplares similares